Silver salt-containing ophthalmic aqueous composition filled in resin container
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsYusuke MOMOKAWA, Maki IIDA, Hiroyuki ASADA, Toyomi FUJISAWA
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsYusuke MOMOKAWA, Maki IIDA, Hiroyuki ASADA, Toyomi FUJISAWA
Estimating the term…
The present invention relates to an ophthalmic aqueous composition containing a silver salt, and filled in a container made of a polyester-based resin, or a container made of a polyolefin-based resin excluding polypropylene. Besides, the present invention also relates to an ophthalmic preservative containing a silver salt, and filled in a container made of a polyester-based resin or a container made of a polyolefin-based resin excluding polypropylene, and a method for imparting, to an ophthalmic aqueous composition, preservative efficacy satisfying a criterion of Preservatives-Effectiveness Tests of The Japanese Pharmacopoeia, including adding a silver salt to the ophthalmic aqueous composition, and filling the ophthalmic aqueous composition in a container made of a polyester-based resin or a container made of a polyolefin-based resin excluding polypropylene. The present invention provides a preservative/system widely usable in ophthalmic aqueous compositions regardless of types of active ingredients and additives.
An ophthalmic aqueous composition comprising a silver salt, the ophthalmic aqueous composition being filled in a container made of a polyester-based resin, or a container made of a polyolefin-based resin excluding polypropylene.
An ophthalmic aqueous composition comprising rebamipide, polyvinylpyrrolidone, and silver nitrate, the ophthalmic aqueous composition being filled in a multi-dose polyethylene eye drop container.
An ophthalmic aqueous composition comprising diquafosol sodium, polyvinylpyrrolidone, and silver nitrate, the ophthalmic aqueous composition being filled in a multi-dose polyethylene eye drop container.
An ophthalmic aqueous composition comprising sirolimus, a surfactant, and silver nitrate, the ophthalmic aqueous composition being filled in a multi-dose polyethylene eye drop container.
An ophthalmic aqueous composition comprising 0.00001 to 0.0001% (w/v) of silver nitrate, the ophthalmic aqueous composition being filled in a multi-dose polyethylene terephthalate eye drop container.
An ophthalmic aqueous composition comprising 0.00002 to 0.0001% (w/v) of silver nitrate, the ophthalmic aqueous composition being filled in a multi-dose polyethylene terephthalate eye drop container.
An ophthalmic preservative comprising a silver salt, the ophthalmic preservative being filled in a container made of a polyester-based resin or a container made of a polyolefin-based resin excluding polypropylene.
A method for imparting, to an ophthalmic aqueous composition, preservative efficacy satisfying a criterion of Preservatives-Effectiveness Tests of The Japanese Pharmacopoeia, comprising adding a silver salt to the ophthalmic aqueous composition, and filling the ophthalmic aqueous composition in a container made of a polyester-based resin or a container made of a polyolefin-based resin excluding polypropylene.
Dependencies are inferred from the claim text.